Abstract
Background: The recent outbreaks of novel endemic and pandemic diseases have highlighted the importance of collaborative networks in rapid response to emerging pathogens. Over the last two decades International AIDS Vaccine Initiative (IAVI), with the support of United States Agency for International Development (USAID) and other international donors, has invested in research capacity and infrastructure in Africa. A significant portion of this support has facilitated establishing regional centers of excellence for African scientists to develop and lead a collaborative research agenda, implemented within the IAVI-led Accelerate the Development of Vaccines and New Technologies to Combat the AIDS Epidemic (ADVANCE) program. One such regional center is the University of Nairobi’s Kenya AIDS Vaccine Initiative-Institute of Clinical Research (KAVI-ICR). Objective: We designed and implemented a development program to foster inter-institutional South-South technology transfer within Africa, and address a capacity gap in mucosal research. Methods: KAVI-ICR and IAVI developed standardized mucosal sample collection, processing and technical assay methods; these were subsequently applied into several observational studies, and Phase I HIV vaccines, Varicella zoster virus vaccine, and broadly neutralizing antibodies clinical trials at KAVI-ICR. Thereafter, KAVI-ICR facilitated the technology transfer of the methods, by training staff at regional establishments in Africa. Results: Twelve standardized methodologies were developed for the collection, processing and storage of 10 mucosal sample types. Subsequently, eight regional research centers received training for a variety of clinical and laboratory methodologies; the centers later applied the techniques in follow-up collaborative research. Additionally, the training fostered collaboration while allowing the development of local networks of research groups. Conclusion: By such South-South initiatives, supported by international donors, the development of regional capacity and expertise is realizable. The established expertise can be leveraged when needed, and builds the capability for African scientists to engage at an international level, actively participating in driving internationally relevant research.
Funder
International AIDS Vaccine Initiative
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine